EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Biomarkers in Peri‐Implant Crevicular Fluid of Healthy Implants and Those With Peri‐Implant Diseases: A Systematic Review and Meta‐Analysis

Gerardo La Monaca, Nicola Pranno, Romeo Patini, Antonella Polimeni, Massimo Cordaro, Maria Paola Cristalli

Journal of Oral Pathology & Medicine · 2025-05 · 54 (5) · 267-282

DOI: 10.1111/jop.13612 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Introduction Several biomarkers in peri‐implant crevicular fluid have been studied to diagnose peri‐implant diseases with inconclusive results. This systematic review and meta‐analysis aimed to comprehensively compare data on the levels of biological components in peri‐implant crevicular fluid collected from healthy and diseased implants to identify reliable biomarkers for diagnosing and monitoring peri‐implant disease. Materials and Methods The search strategy included studies comparing biomarker levels in peri‐implant crevicular fluid between healthy and diseased implants through electronic databases (MEDLINE/PubMed, Embase, Cochrane Library), grey literature, and hand‐searching relevant journals and reference lists of pertinent papers. A two‐stage screening was performed in duplicate and independently. In the first stage, titles and abstracts that fulfilled eligibility criteria were screened. In the second stage, a full‐text analysis was conducted to verify eligibility. All articles meeting the inclusion criteria underwent data extraction and quality assessment. Meta‐analyses were conducted on studies with similar comparisons and outcome measures. Results After screening the titles and abstracts, out of 100 potentially relevant papers identified for full‐text evaluation, 49 were excluded, 51 were included in the qualitative analysis, and 18 were included in the quantitative synthesis. Among 96 biomarkers assessed, the most studied were pro‐inflammatory cytokines (IL‐1ß, IL‐6, TNF‐α, and IL‐17), osteoclastogenic‐related factors (RANK, RANKL, and OPG), anti‐inflammatory cytokines (IL‐10), chemokines (IL‐8, MIP‐1α/CCL3, and MIP‐3α/CCL‐20), and enzymes (MMP‐8, Cat‐K, AST, and ALT). Conclusions Meta‐analyses comparing data from healthy patients and those with peri‐implantitis or mucositis and between patients with mucositis and those with peri‐implantitis showed a moderate predictive value of IL‐1ß, VEGF, cortisol, and sRANKL/OPG for peri‐implantitis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →